Skip to content

The effect of Matricaria Chamomilla capsules on menstrual pattern and Premenstrual Syndrome symptoms in students living in dormitories of Guilan University of Medical Sciences in the years 2016-2017

The effect of Matricaria Chamomilla capsules on menstrual pattern and Premenstrual Syndrome symptoms in students living in dormitories

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705214295N3
Enrollment
118
Registered
2017-05-27
Start date
2017-06-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Syndrome , menstrual pattern. Premenstrual tension syndrome

Interventions

Intervention 1: Intervention group : This group will use seven days before menstruation, every 8 hours 1 capsule contains 250 mg of dried chamomile. Intervention 2: control group : This group will use
Treatment - Drugs
Intervention group : This group will use seven days before menstruation, every 8 hours 1 capsule contains 250 mg of dried chamomile.
control group : This group will use seven days before menstruation every 8 hours 1 capsule containing starch (Which is in shape like chamomile capsules)

Sponsors

Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:age within 18-35 years; normal body mass index(BMI=19.8-26); being single; regular menstrual cycle (21e35 days);with diagnosed moderate to severe symptoms of premenstrual syndrome; desiring to participate in the study; no physical, psychological or gynecological ill conditions; not on medication; not having history of pelvic or abdominal surgery; not taking smoke; not using drugs; not using alcohol; no stressful event occurrence in the last six months; no surgical operation during the last six months; not being a professional athlete. Exclusion Criteria: taking medications during the study; improper use of capsules; not wanting to continue treatment; allergy to Matricaria Chamomilla

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of menstrual cycle. Timepoint: Menstrual cycle before intervention,Menstrual cycle after intervention. Method of measurement: The time interval from the first day of menstrual bleeding and menstrual cycles after the first day. Based on the response to the questionnaire.;The severity of premenstrual syndrome. Timepoint: Menstrual cycle before intervention,Menstrual cycle after intervention. Method of measurement: PSST standard questionnaire.;Duration of menstrual bleeding . Timepoint: Menstrual cycle before intervention,Menstrual cycle after intervention. Method of measurement: The time interval from the first day until the last day of menstrual bleeding menstrual bleeding in a cycle. Based on the response to the questionnaire.;The amount of menstrual bleeding. Timepoint: Menstrual cycle before intervention,Menstrual cycle after intervention. Method of measurement: Hygam standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Ziaie

Guilan University of Medical Sciences

Taherehziai@gums.ac.ir+98 13 3355 5056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026